Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of silymarin 700 mg thrice daily
and assess the safety in patients with hepatitis C virus infection compared to a placebo.